NCT00242879 - A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Infection, Human Immunodeficiency Virus IHIV-1 Infection

Interventions

DRUG

Physician determined comparator PI + ritonavir

DRUG

GW640385 + ritonavir

Trial Locations (70)

1000

GSK Investigational Site, Brussels

1150

GSK Investigational Site, Lisbon

2010

GSK Investigational Site, Darlinghurst

2170

GSK Investigational Site, Liverpool

2750

GSK Investigational Site, Cascais

3141

GSK Investigational Site, South Yarra

7102

GSK Investigational Site, Newark

10149

GSK Investigational Site, Turin

13353

GSK Investigational Site, Berlin

14000

GSK Investigational Site, Caen

14604

GSK Investigational Site, Rochester

20007

GSK Investigational Site, Washington D.C.

20009

GSK Investigational Site, Washington D.C.

20099

GSK Investigational Site, Hamburg

20127

GSK Investigational Site, Milan

21201

GSK Investigational Site, Baltimore

23666

GSK Investigational Site, Hampton

27100

GSK Investigational Site, Pavia

29605

GSK Investigational Site, Greenville

33140

GSK Investigational Site, Miami Beach

33306

GSK Investigational Site, Fort Lauderdale

33308

GSK Investigational Site, Fort Lauderdale

33316

GSK Investigational Site, Fort Lauderdale

34205

GSK Investigational Site, Bradenton

40202

GSK Investigational Site, Louisville

44093

GSK Investigational Site, Nantes

44100

GSK Investigational Site, Ferrara

45122

GSK Investigational Site, Essen

46202

GSK Investigational Site, Indianapolis

47900

GSK Investigational Site, Rimini

50126

GSK Investigational Site, Bagno A Ripoli (FI)

53127

GSK Investigational Site, Bonn

60590

GSK Investigational Site, Frankfurt am Main

60613

GSK Investigational Site, Chicago

60657

GSK Investigational Site, Chicago

69288

GSK Investigational Site, Lyon

69437

GSK Investigational Site, Lyon

70124

GSK Investigational Site, Bari

75246

GSK Investigational Site, Dallas

75475

GSK Investigational Site, Paris

75571

GSK Investigational Site, Paris

77027

GSK Investigational Site, Houston

80204

GSK Investigational Site, Denver

80220

GSK Investigational Site, Denver

80335

GSK Investigational Site, Munich

85006

GSK Investigational Site, Phoenix

85025

GSK Investigational Site, La Roche-sur-Yon

89102

GSK Investigational Site, Las Vegas

90046

GSK Investigational Site, Los Angeles

92708

GSK Investigational Site, Fountain Valley

93301

GSK Investigational Site, Bakersfield

94115

GSK Investigational Site, San Francisco

94121

GSK Investigational Site, San Francisco

700116

GSK Investigational Site, Iași

900709

GSK Investigational Site, Constanța

06851

GSK Investigational Site, Norwalk

60612-7230

GSK Investigational Site, Chicago

02118

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

V6Z 2C7

GSK Investigational Site, Vancouver

M4N 3M5

GSK Investigational Site, Toronto

M5B 1L6

GSK Investigational Site, Toronto

H2L 4P9

GSK Investigational Site, Montreal

H2X 2P4

GSK Investigational Site, Montreal

G1V 4G2

GSK Investigational Site, Sainte-Foy

00731

GSK Investigational Site, Ponce

00909-1711

GSK Investigational Site, San Juan

021105

GSK Investigational Site, Bucharest

EC1 7BE

GSK Investigational Site, London

SW10 9TH

GSK Investigational Site, London